BPC-157 Mechanism: The VEGF/Akt/eNOS Chain and Controlled Angiogenesis BPC-157 (Body Protection Compound 157) is a fragment of the gastric protein BPC, first isolated and characterized by Predrag Sikiric's team at the University of Zagreb in 1993
Its levels decline significantly as we age
Supplementing with liposomal glutathione may be particularly beneficial during these times of increased demand.* Mechanism of Action Reduced Glutathione for Master Antioxidant Support* 100 mg of glutathione in its reduced (active) form provides direct antioxidant protection against harmful molecules from diet, environmental sources, and normal bodily processes
It does not prove that longer use leads to better results
For some, a B12 injection is the fastest and most effective way to ensure their body gets what it needs
4-5 FDA APPROVED FOR 1-3 Gastrointestinal Strongyloidiasis Onchocerciasis OFF-LABEL DERMATOLOGIC USES Scabies Cutaneous demodicosis Refractory body/head lice Pediculosis palpebrarum Ocular and cutaneous rosacea Blepharitis Cutaneous larva migrans Cutaneous larva currens Myiasis Cutaneous gnathostomiasis Filariasis DOSING 8 Oral ivermectin dosing is variable depending on the condition being treated and the patients response